IP Library Granted Patent US 8,092,490
Granted Patent B2
US 8,092,490 · App. 11/204,958 · Granted Jan 10, 2012

Photochemical tissue bonding

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,092,490
App. No.
11/204,958
Granted
Jan 10, 2012
Kind
B2
Abstract

Photochemical tissue bonding methods include the application of a photosensitizer to a tissue and/or tissue graft, followed by irradiation with electromagnetic energy to produce a tissue seal. The methods are useful for tissue adhesion, such as in wound closure, tissue grafting, skin grafting, musculoskeletal tissue repair, ligament or tendon repair and corneal repair.

Claims (28)

1. A method for adhering tissue, comprising: contacting a tissue, a tissue substitute, and at least one photosensitizer agent to form a tissue-photosensitizer complex; and applying electromagnetic energy to the tissue-photosensitizer complex in a manner effective to create covalent crosslinks between the tissue and tissue substitute, wherein the tissue or tissue substitute is not contacted with an adhesive comprising an exogenous protein or peptide which is crosslinked by the application of electromagnetic energy, thereby creating a seal having a tensile strength between the tissue and the tissue substitute.

2. The method of claim 1 , wherein the tissue substitute comprises any member of the group consisting of silicon, collagen, fibronectin, glycosaminoglycan, polyurethane, polyvinyl and nylon.

3. The method of claim 1 , wherein the tissue substitute is comprised of collagen.

4. The method of claim 3 , wherein the collagen is in a gel.

5. The method of claim 1 , wherein the tissue substitute is cellular.

6. The method of claim 1 , wherein the tissue substitute is impregnated with the photosensitizer agent prior to contacting the first tissue.

7. The method of claim 1 , wherein the tissue substitute is an engineered tissue implant.

8. The method of claim 1 , wherein the contacting steps occurs ex vivo.

9. The method of claim 1 , wherein the contacting steps occur in vivo in a subject.

10. The method of claim 9 , wherein the subject is a human.

11. The method of claim 9 , wherein the tissue substitute is repopulated with cells from the subject after creating the tissue seal.

12. The method of claim 1 , wherein the tissue is selected from the group consisting of cardiovascular, neurological, gastrointestinal, renal, urological, oral, respiratory, otolaryngological, dermatological, gynecological, genital and connective tissue.

13. The method of claim 1 , wherein the tissue is skin.

14. The method of claim 1 , wherein the at least one photosensitizer agent is Rose Bengal.

15. The method of claim 1 , wherein the at least one photosensitizer agent is riboflavin-5-phosphate.

16. The method of claim 1 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 15° C. rise in temperature.

17. The method of claim 1 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 10° C. rise in temperature.

18. The method of claim 1 , wherein the application of electromagnetic energy to the tissue-photosensitizer complex occurs without more than a 3° C. rise in temperature.

19. The method of claim 1 , wherein the electromagnetic energy applied is less than 2000 J/cm 2 .

20. The method of claim 1 , wherein the electromagnetic energy is applied at an irradiance less than 1.5 W/cm 2 .

21. The method of claim 1 , wherein the electromagnetic energy is applied at an irradiance of about 0.60 W/cm 2 .

22. The method of claim 1 , wherein the electromagnetic energy has a wavelength of at least 488 nm and is applied at an irradiance less than 3.5 W/cm 2 .

23. The method of claim 1 , wherein the electromagnetic energy is applied at an irradiance of about 0.25 W/cm 2 .

24. The method of claim 1 , wherein the electromagnetic energy applied is about 50 J/cm 2 .

25. The method of claim 1 , wherein the electromagnetic energy applied is about 100 J/cm 2 .

26. The method of claim 1 , wherein the tensile strength between the first tissue and the tissue substitute is 0.15 N/cm 2 .

27. The method of claim 1 , wherein the tensile strength between the first tissue and the tissue substitute is 0.13 N/cm 2 .

28. The method of claim 1 , wherein the step of applying electromagnetic energy bonds the tissue to the tissue substitute without producing substantial thermal damage.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 10, 2010
From: JOHNSON & JOHNSON DEVELOPMENT CORPORATION
To: AURA MEDSYSTEMS, INC.
Reel/Frame 024505/0983 →
SECURITY AGREEMENT Recorded Jun 17, 2009
From: AURA MEDSYSTEMS, INC.
To: JOHNSON & JOHNSON DEVELOPMENT CORPORATION
Reel/Frame 022835/0549 →
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 022764, FRAME 0018. ASSIGNORS HEREBY CONFIRM THE LICENSE. Recorded Jun 4, 2009
From: GENERAL HOSPITAL CORPORATION, THE, D/B/A MASSACHUSETTS GENERAL HOSPITAL; MASSACHUSETTS EYE AND EAR INFIRMARY
To: AURA MEDSYSTEMS, INC.
Reel/Frame 022868/0138 →
LICENSE Recorded Jun 2, 2009
From: THE GENERAL HOSPTIAL CORPORATION, D/B/A/ MASSACHUSETTS GENERAL HOSPITAL; MASSACHUSETTS EYE AND EAR INFIRMARY
To: AURA MEDSYSTEMS, INC.
Reel/Frame 022764/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2008
From: REDMOND, ROBERT W.; KOCHEVAR, IRENE E.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 021299/0327 →
Continuity (5)
Division 10094120 · Mar 8, 2002
Continuation In Part 09900504 · Jul 6, 2001
Continuation In Part 09781577 · Feb 12, 2001
Provisional Application 60181980 · Feb 11, 2000
Related Publication 20060212070A1 · Sep 21, 2006